<DOC>
	<DOCNO>NCT02968680</DOCNO>
	<brief_summary>This pilot phase I trial study well sonazoid-enhanced ultrasound work detect sentinel lymph node patient cutaneous melanoma . Sonazoid contrast agent may make easy see tumor cell spread sentinel lymph node use ultrasound .</brief_summary>
	<brief_title>Sonazoid-Enhanced Ultrasound Detecting Sentinel Lymph Node Patients With Cutaneous Melanoma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To study image feasibility peri-tumoral administration sonazoid ultrasound contrast agent assessment sentinel lymph node ( SLN ) detection melanoma . II . To compare SLN detection sonazoid ultrasound standard care ( SOC ) technique . SECONDARY OBJECTIVES : I . To assess sonazoid ultrasound ( US ) image appearance lymph node show involved metastatic disease . OUTLINE : Patients receive sonazoid intradermally ( ID ) undergo ultrasound imaging . Patients also undergo standard care sentinel lymph node biopsy ( SLNB ) . After completion study treatment , patient follow 24 48 hour .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Cutaneous melanoma Breslow depth &gt; 1 mm melanoma Breslow depth 0.76 1.00 mm set ulceration , extensive regression Mitotic rate &gt; = 1/mm^2 Presence angiolymphatic invasion Deep positive margin No known allergy contrast material Pregnant nursing Patients know cardiac shunt Patients class II heart failure bad , per New York Heart Association ( NYHA ) classification Patients experience acute coronary syndrome angina past 6 month Patients undergone coronary artery bypass grafting ( CABG ) coronary stenting past 3 year Patients evidence moderate severe cardiac valvular disease echocardiogram Patients evidence moderate severe pulmonary hypertension echocardiogram Patients stage II chronic obstructive pulmonary disease ( COPD ) bad , per Global Initiative Chronic Obstructive Lung Disease ( GOLD ) classification Patients hypersensitivity sonazoid one component Patients hypersensitivity egg egg product , sonazoid contains chicken eggderived surfactant ( hydrogenate egg phosphatidylserine sodium ) Patients consent</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>